Haw Par (H4V) Stock Overview

Manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally. More details

H4V fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	1/6
Past Performance	4/6
Financial Health	5/6
Dividends	3/6

Rewards

Price-To-Earnings ratio (13.5x) is below the German market (17.2x)

Earnings are forecast to grow 3.14% per year

Earnings grew by 16.3% over the past year

Risk Analysis

Highly volatile share price over the past 3 months compared to the German market

Dividend of 2.47% is not well covered by free cash flows

H4V Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

Haw Par Corporation Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Haw Par
Historical stock prices
Current Share Price	S$10.00
52 Week High	S$14.78
52 Week Low	S$9.14
Beta	0.16
1 Month Change	-1.77%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	9.47%

Recent updates

Shareholder Returns

	H4V	DE Pharmaceuticals	DE Market
7D	0%	2.0%	0.1%
1Y	n/a	30.0%	4.5%

Return vs Industry: Insufficient data to determine how H4V performed against the German Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how H4V performed against the German Market.

Price Volatility

Is H4V's price volatile compared to industry and market?
H4V volatility
H4V Average Weekly Movement	28.5%
Pharmaceuticals Industry Average Movement	5.9%
Market Average Movement	5.8%
10% most volatile stocks in DE Market	13.7%
10% least volatile stocks in DE Market	2.8%

Stable Share Price: H4V's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine H4V's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1969	n/a	Ee Lim Wee	www.hawpar.com

Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities. The company also owns and leases various investment properties.

Haw Par Corporation Limited Fundamentals Summary

How do Haw Par's earnings and revenue compare to its market cap?
H4V fundamental statistics
Market cap	€2.42b
Earnings (TTM)	€179.15m
Revenue (TTM)	€155.20m

13.5x

P/E Ratio

15.6x

P/S Ratio

Is H4V overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
H4V income statement (TTM)
Revenue	S$229.97m
Cost of Revenue	S$101.20m
Gross Profit	S$128.77m
Other Expenses	-S$136.70m
Earnings	S$265.46m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	1.20
Gross Margin	55.99%
Net Profit Margin	115.43%
Debt/Equity Ratio	1.0%

How did H4V perform over the long term?

See historical performance and comparison

Dividends

2.5%

Current Dividend Yield

33%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/17 02:36
End of Day Share Price	2026/06/17 00:00
Earnings	2025/12/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Haw Par Corporation Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jayden Vantarakis	Macquarie Research

Haw Par Corporation LimitedDB:H4V Stock Report